PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 128 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $347,470 | -16.4% | 10,028 | -30.2% | 0.00% | – |
| Q1 2024 | $415,695 | +25.6% | 14,369 | -0.4% | 0.00% | – |
| Q4 2023 | $330,857 | +32.5% | 14,429 | -3.6% | 0.00% | – |
| Q3 2023 | $249,717 | -35.0% | 14,971 | +7.7% | 0.00% | – |
| Q2 2023 | $384,000 | +23.5% | 13,903 | +2.8% | 0.00% | – |
| Q1 2023 | $311,029 | +142.9% | 13,523 | +15.2% | 0.00% | – |
| Q4 2022 | $128,062 | +47.2% | 11,738 | +13.4% | 0.00% | – |
| Q3 2022 | $87,000 | -66.5% | 10,349 | +36.0% | 0.00% | – |
| Q4 2021 | $260,000 | -65.0% | 7,607 | -54.0% | 0.00% | – |
| Q2 2021 | $743,000 | +250.5% | 16,540 | +102.3% | 0.00% | – |
| Q1 2021 | $212,000 | – | 8,176 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $84,864,191 | 21.18% |
| Cannon Global Investment Management, LLC | 69,900 | $2,422,035 | 11.28% |
| ADAR1 Capital Management, LLC | 1,603,932 | $55,576,244 | 10.49% |
| Checkpoint Capital L.P. | 355,000 | $12,300,750 | 7.42% |
| Fairmount Funds Management LLC | 931,890 | $32,289,989 | 3.65% |
| BVF INC/IL | 3,319,290 | $115,013,399 | 3.22% |
| RTW INVESTMENTS, LP | 5,286,404 | $183,173,899 | 2.84% |
| Kynam Capital Management, LP | 800,000 | $27,720,000 | 2.14% |
| 683 Capital Management, LLC | 604,449 | $20,944,158 | 1.58% |
| Birchview Capital, LP | 48,000 | $1,663,200 | 1.54% |